Latest Content

Trial to Investigate Experimental Drug’s Effect on Improving Survival in Refractory Myelofibrosis

May 11th 2021, 9:00pm

By Ryan McDonald

Article

The Geron Corporation announced that the first patient has been dosed with GRN163L — an experimental agent — in a phase 3 clinical trial to assess the drug’s overall survival benefit compared to best available therapy in patients with refractory myelofibrosis.

Early Study Results Show Novel Therapy Safe and Effective in Relapsed/Refractory Acute Myeloid Leukemia

May 11th 2021, 6:00pm

By Ryan McDonald

Article

Treatment with a novel therapy as a single agent, or in combination with Venclexta, demonstrated a manageable safety profile and antileukemic effects in patients with relapsed/refractory acute myeloid leukemia. The study authors, however, note that more research is needed.

My Nemesis the Gold-Capped Vial

May 11th 2021, 4:00pm

By Marissa Holzer

Article

A woman with metastatic breast cancer describes the overwhelming dread she feels every time she must wait to hear the results of a tumor marker test.

Patients with Hematologic Cancers Benefit from a Walking Program

May 11th 2021, 3:00pm

By Jessica Skarzynski

Article

Prior to the program, patients with hematologic cancers walked an average of 136 steps in a 24-hour period. One month after the program began, that total increased to an average of 1,018 steps per day.

Jakafi-Novel Therapy Combo Improves Symptom Burden in Patients with Myelofibrosis

May 11th 2021, 1:00pm

By Ryan McDonald

Article

Treatment with daily Jakafi and parsaclisib improved spleen volume reduction and symptom burden in patients with myelofibrosis who had previously failed to achieve significant response to single-agent Jakafi.

The Role of Tumor Infiltrating Lymphocyte (TIL) Therapy in NSCLC

May 11th 2021, 12:45pm

By CURE Media Group

Video

An expert in thoracic oncology, Adam J. Schoenfeld, MD, provides key insight into the use of cell therapy in non-small cell lung cancer after first-line treatment and highlights the potential for tumor-infiltrating lymphocyte (TIL) therapy depending on results from ongoing clinical trials.

Doctor’s Experience as a Cancer Caregiver Is Helping Educate Others

May 10th 2021, 9:00pm

By Darlene Dobkowski, MA

Article

A gynecologic oncologist who has spent her career helping patients during their cancer journeys goes a step further to educate women on how to advocate for themselves and possibly prevent cancer before it occurs.

Patients with Rare Cancers Offer Others Who May Be Facing a Similar Diagnosis Advice

May 10th 2021, 6:00pm

By Ryan McDonald

Article

On social media, CURE® recently asked its readers with rare cancers what advice they would offer to fellow patients with a similar diagnosis. Here’s what they shared.

A Pep Talk On COVID-19 Vaccinations From a Cancer Survivor

May 10th 2021, 4:00pm

By Felicia Mitchell

Article

Some experiences we have as cancer survivors may help inspire those reluctant to get or complete COVID-19 vaccinations to follow through. We are all role models for each other.

Neoadjuvant Libtayo Shows Promise for Patients With Hepatocellular Carcinoma

May 10th 2021, 3:00pm

By Colleen Moretti

Article

Twenty percent of patients with resectable hepatocellular carcinoma had a significant amount of cell death when receiving Libtayo before surgical intervention.

Significant Disagreements Among Patients With Blood Cancers and Oncologists Persist Regarding Prognosis and Goals of Care

May 10th 2021, 1:00pm

By Colleen Moretti

Article

There is a difference between patient and oncologists regarding prognosis, and patients are lacking understanding of prognosis and interventions needed to help them make more informed treatment choices.

Mothering a Daughter with Cancer

May 9th 2021, 6:00pm

By Debbie Legault

Article

A mother and caregiver describes how she views each moment with her daughter differently after her daughter’s breast cancer diagnosis.

Our Microbiome: A Reflection of Ourselves?

May 9th 2021, 3:00pm

By Debu Tripathy, M.D.

Article

Sophisticated analyses can predict which gut microbiome profile may lead to better outcomes to immunotherapy for patients with advanced melanoma.

How Can Cancer Survivors Help The Newly Diagnosed?

May 8th 2021, 6:00pm

By Bonnie Annis

Article

Cancer survivors have the responsibility of sharing their knowledge of living in the world of cancer with the newly diagnosed, writes one survivor. Here, she shares ways to offer help.

CURE Honors World Ovarian Cancer Day

May 8th 2021, 3:00pm

By Jessica Skarzynski

Article

Today is World Ovarian Cancer Day, and in honor of this day that was created in 2013 to raise awareness about the disease, CURE® is rounding up the latest news and updates in this cancer space.